Phase 2a study of the phosphatidylinositol-3-kinase (PI3K) inhibitor copanlisib in patients with relapsed/refractory, indolent or aggressive lymphoma.

4.00
Hdl Handle:
http://hdl.handle.net/10541/620062
Title:
Phase 2a study of the phosphatidylinositol-3-kinase (PI3K) inhibitor copanlisib in patients with relapsed/refractory, indolent or aggressive lymphoma.
Authors:
Dreyling, M; Morschhauser, F; Bouabdallah, K; Cunningham, D; Bron, D; Linton, Kim M ( 0000-0002-3294-1548 ) ; Assouline, S; Verhoef, G; Thieblemont, C; Vitolo, U; Garcia-Vargas, J; Gorbatchevsky, I; Neves, M; Grunert, J; Hiemeyer, F; Childs, B; Zinzani, P
Affiliation:
Universitatsklinik Grosshadern/LMU, Medizinische Klinik 111, Munchen
Citation:
Phase 2a study of the phosphatidylinositol-3-kinase (PI3K) inhibitor copanlisib in patients with relapsed/refractory, indolent or aggressive lymphoma. 2016, 39: 310-310 Oncol Res Treat
Journal:
Oncology Research and Treatment
Issue Date:
2016
URI:
http://hdl.handle.net/10541/620062
Type:
Meetings and Proceedings
Language:
en
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorDreyling, Men
dc.contributor.authorMorschhauser, Fen
dc.contributor.authorBouabdallah, Ken
dc.contributor.authorCunningham, Den
dc.contributor.authorBron, Den
dc.contributor.authorLinton, Kim Men
dc.contributor.authorAssouline, Sen
dc.contributor.authorVerhoef, Gen
dc.contributor.authorThieblemont, Cen
dc.contributor.authorVitolo, Uen
dc.contributor.authorGarcia-Vargas, Jen
dc.contributor.authorGorbatchevsky, Ien
dc.contributor.authorNeves, Men
dc.contributor.authorGrunert, Jen
dc.contributor.authorHiemeyer, Fen
dc.contributor.authorChilds, Ben
dc.contributor.authorZinzani, Pen
dc.date.accessioned2016-12-16T16:21:25Z-
dc.date.available2016-12-16T16:21:25Z-
dc.date.issued2016-
dc.identifier.citationPhase 2a study of the phosphatidylinositol-3-kinase (PI3K) inhibitor copanlisib in patients with relapsed/refractory, indolent or aggressive lymphoma. 2016, 39: 310-310 Oncol Res Treaten
dc.identifier.urihttp://hdl.handle.net/10541/620062-
dc.language.isoenen
dc.titlePhase 2a study of the phosphatidylinositol-3-kinase (PI3K) inhibitor copanlisib in patients with relapsed/refractory, indolent or aggressive lymphoma.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentUniversitatsklinik Grosshadern/LMU, Medizinische Klinik 111, Munchenen
dc.identifier.journalOncology Research and Treatmenten
dc.description.collectionLymphoma Research Teamen
All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.